Cognition Therapeutics, Inc. (CGTX) Free cash flow 2020–2024
Cognition Therapeutics, Inc. (CGTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$28.5MFY2024 · since FY2020: -$3.4M → -$28.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$28.5M | -76.2% |
| FY2023 | -$16.2M | +13.6% |
| FY2022 | -$18.7M | -411.3% |
| FY2021 | -$3.7M | -6.2% |
| FY2020 | -$3.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice